Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03136367 · ClinicalTrials.gov registry record · NA
What Matters Most: Choosing the Right Breast Cancer Surgery for You
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 571
- Enrollment target
NCT03136367 is a NA study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 571 participants.
The verdict
NCT03136367, a NA study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 571 participants
- Enrollment target
Study Summary
What Matters Most is a study that aims to determine how best to help women of lower socioeconomic status make high-quality decisions about early stage breast cancer treatments. What Matters Most will be comparing two decision aids used in the clinic visit to usual care (what normally happens in the clinic). The first decision aid (Option Grid) presents evidence-based information about lumpectomy and mastectomy in a tabular format using text only. The second decision aid (Picture Option Grid) presents evidence-based information about lumpectomy and mastectomy using pictures, pictographs and simplified text. What Matters Most aims to show that the interventions can reduce disparities in decision-making and treatment choice between women of high and low SES.
Interventions
- OTHER Option Grid
- OTHER Picture Option Grid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 571 participants |
| Start Date | 2017-09-18 |
| Est. Completion | 2019-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03136367
The ClinicalTrials.gov registry entry for NCT03136367 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 571 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Option Grid is the first listed.
NCT03136367 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03136367 about?
NCT03136367 is a clinical study titled "What Matters Most: Choosing the Right Breast Cancer Surgery for You". What Matters Most is a study that aims to determine how best to help women of lower socioeconomic status make high-quality decisions about early stage breast cancer treatments. What Matters Most will be comparing two decision aids used in the clinic visit to usual care (what normally happens in the ...
What is the current status of trial NCT03136367?
This trial is currently completed. It is a NA study. The enrollment target is 571 participants. The study started on 2017-09-18. Estimated completion is 2019-05-31.
What interventions are being tested in trial NCT03136367?
The interventions under investigation include: Option Grid (OTHER), Picture Option Grid (OTHER).
Who is sponsoring clinical trial NCT03136367?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.